Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 64 results for "cadila healthcare"

Cadila Healthcare up 1% on USFDA final approval for Allopurinol tablets
Money Control

Cadila Healthcare up 1% on USFDA final approval for Allopurino...

Zydus Cadila has received final approval from the USFDA to market Allopurinol Tablets USP, 100 mg and 300 mg. Money Control, 5 days ago

38 images for cadila healthcare

Money Control, 5 days ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 2 weeks ago
Money Control, 3 weeks ago
Money Control, 4 weeks ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 4 weeks ago
Money Control

Cadila Healthcare recovers after getting USFDA nod for drug

Cadila Healthcare gained 1.36% to Rs 498.05 at 14:#0 IST on BSE after the company said that it received final approval from the US drug regulator to market Desvenlafaxine Extended-Release Tablets, 50 mg and 100 mg.
 Business Standard1 week ago Cadila Healthcare advances after receiving USFDA nod for drugs  Business Standard1 week ago Cadila Healthcare receives USFDA nod for two drugs  Business Standard1 month ago Pharma wrap: Dr Reddy#39;s German observation, Cadila clearing US inspection more  Money Control1 month ago

Cadila among few bright spots in pharma space

Unlike many of its pharma peers, there has been a slew of goods news for Cadila Healthcare in recent times. While its Moraiya plant recently got clearance of the US FDA, Cadila has also received almost a dozen approvals for new launches in the US since ...
 Business Standard2 weeks ago Pharma stocks see relief rally; index up 3 pct  Sify1 month ago Pharma weekly wrap: Pharma stocks had tough week due to GST and pricing pressures in US  Money Control2 months ago

Glenmark's Glenn Saldanha appointed IPA President

Indian Pharmaceutical Alliance (IPA), a body of major domestic pharma firms, today said Glenn Saldanha has been appointed as President for 2017-19.Saldanha is Chairman & Managing Director of Glenmark Pharmaceuticals.IPA also appointed Panacea Biotec Joint ...
 Business Standard5 days ago

Zydus and Pharm Aid tie up for vaccine technology for Russia

Cadila Healthcare Limited (Zydus Cadila), has entered into an exclusive agreement for the technology know-how for varicella vaccine production in the Russian Federation with Pharm Aid Ltd, headquartered in Russia. Pharm Aid Ltd, has been set up by Nacimbio ...
 Business Standard1 month ago Cadila Healthcare enters into exclusive agreement with Pharm Aid, Russia  Business Standard1 month ago

Want to significantly expand emerging market business: Cadila

In a rare television appearance, Cadila Healthcare#39;s relatively new Managing Director, Sharvil Patel spoke with CNBC-TV18#39;s Ekta Batra on a whole host of issues including their hope of becoming India#39;s number one oncology player within the next 5 ...
 Money Control2 weeks ago Cadila Healthcare net profit down 65.26% in Q1  Prokerala2 months ago Cadila Healthcare Q1 PAT down 30% as GST hurts domestic business  Business Standard2 months ago
Money Control

Likely competition for generic Lialda bears on Cadila's stocks

Copy Begins/Cadila Healthcare's (Zydus Cadila) blockbuster drug the generic version of mesalamine (Lialda) is likely to face competition from the innovator itself as Irish pharma firm Shire Plc is expected to launch an authorised generic (AG) version of the ...
 Business Standard1 month ago Cadila Healthcare falls 5% on worry over increased competition for Lialda generic  Money Control1 month ago Father and son Transform Cadila Health to a world beater  The Financial Chronicle2 months ago

Cadila Healthcare falls over 3% on ratings downgrade to ‘reduce’

IIFL observed that the stock has already priced in upside from big launches and valuations are also on the higher side.
 Money Control3 weeks ago

Of Cadila Healthcare, ICICI Lombard IPO & Other Top Cues in Action Today

Posted by Equitymaster Indian share markets continued to trade flat in Friday's session as geopolitical tensions escalated in far east following another missile launch by North Korea that dampened the sentiment . Even so, Indian markets put up their best ...
 Equitymaster.com1 month ago Flat Finish to the Week; Cadila Healthcare Rallies 7%  Equitymaster.com1 month ago US Fed Meet, SBI Life IPO and Other Top Cues in Action Today  Equitymaster.com1 month ago Global Markets Tumble as Geopolitical Tensions Escalate  Equitymaster.com2 months ago
Money Control

Zydus settles patent case over Aptalis' drug Canasa

Zydus group firm Cadila Healthcare today said patent litigation relating to Aptalis' drug Canasa used for treatment of ulcerative colitis has been settled. As a result of the settlement, the company's "US subsidiary, Zydus Pharmaceuticals (USA) Inc, will be ...
 Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less